nodes	percent_of_prediction	percent_of_DWPC	metapath
Nafarelin—Nasal irritation—Fluorouracil—colon cancer	0.0579	0.0579	CcSEcCtD
Nafarelin—Prolonged menses—Vincristine—colon cancer	0.0514	0.0514	CcSEcCtD
Nafarelin—Nasal discomfort—Fluorouracil—colon cancer	0.0351	0.0351	CcSEcCtD
Nafarelin—Hypovolaemia—Irinotecan—colon cancer	0.0338	0.0338	CcSEcCtD
Nafarelin—Ascites—Capecitabine—colon cancer	0.0154	0.0154	CcSEcCtD
Nafarelin—Menorrhagia—Vincristine—colon cancer	0.0145	0.0145	CcSEcCtD
Nafarelin—Transient ischaemic attack—Capecitabine—colon cancer	0.0139	0.0139	CcSEcCtD
Nafarelin—Hirsutism—Capecitabine—colon cancer	0.0121	0.0121	CcSEcCtD
Nafarelin—Pulmonary fibrosis—Methotrexate—colon cancer	0.0119	0.0119	CcSEcCtD
Nafarelin—Deep vein thrombosis—Capecitabine—colon cancer	0.0115	0.0115	CcSEcCtD
Nafarelin—Loss of libido—Methotrexate—colon cancer	0.0113	0.0113	CcSEcCtD
Nafarelin—Herpes simplex—Fluorouracil—colon cancer	0.0109	0.0109	CcSEcCtD
Nafarelin—Interstitial pneumonia—Methotrexate—colon cancer	0.0108	0.0108	CcSEcCtD
Nafarelin—Pulmonary embolism—Irinotecan—colon cancer	0.0105	0.0105	CcSEcCtD
Nafarelin—Vaginal haemorrhage—Capecitabine—colon cancer	0.00948	0.00948	CcSEcCtD
Nafarelin—Neoplasm—Irinotecan—colon cancer	0.00948	0.00948	CcSEcCtD
Nafarelin—Pleural effusion—Capecitabine—colon cancer	0.00916	0.00916	CcSEcCtD
Nafarelin—Rash maculo-papular—Fluorouracil—colon cancer	0.00913	0.00913	CcSEcCtD
Nafarelin—Vaginal discharge—Methotrexate—colon cancer	0.00859	0.00859	CcSEcCtD
Nafarelin—Deep vein thrombosis—Methotrexate—colon cancer	0.00859	0.00859	CcSEcCtD
Nafarelin—Cerebrovascular accident—Irinotecan—colon cancer	0.00777	0.00777	CcSEcCtD
Nafarelin—Herpes simplex—Capecitabine—colon cancer	0.00761	0.00761	CcSEcCtD
Nafarelin—Interstitial lung disease—Methotrexate—colon cancer	0.00738	0.00738	CcSEcCtD
Nafarelin—Coordination abnormal—Capecitabine—colon cancer	0.00714	0.00714	CcSEcCtD
Nafarelin—Pulmonary embolism—Capecitabine—colon cancer	0.00702	0.00702	CcSEcCtD
Nafarelin—Muscular weakness—Vincristine—colon cancer	0.00689	0.00689	CcSEcCtD
Nafarelin—Pleural effusion—Methotrexate—colon cancer	0.00682	0.00682	CcSEcCtD
Nafarelin—Urinary incontinence—Capecitabine—colon cancer	0.00677	0.00677	CcSEcCtD
Nafarelin—Dry skin—Fluorouracil—colon cancer	0.00668	0.00668	CcSEcCtD
Nafarelin—Abdominal distension—Irinotecan—colon cancer	0.00662	0.00662	CcSEcCtD
Nafarelin—Muscular weakness—Fluorouracil—colon cancer	0.00643	0.00643	CcSEcCtD
Nafarelin—Sweating increased—Irinotecan—colon cancer	0.00641	0.00641	CcSEcCtD
Nafarelin—Neoplasm—Capecitabine—colon cancer	0.00634	0.00634	CcSEcCtD
Nafarelin—Dysuria—Vincristine—colon cancer	0.00632	0.00632	CcSEcCtD
Nafarelin—Weight decreased—Vincristine—colon cancer	0.00611	0.00611	CcSEcCtD
Nafarelin—Depression—Vincristine—colon cancer	0.006	0.006	CcSEcCtD
Nafarelin—Ear pain—Capecitabine—colon cancer	0.00597	0.00597	CcSEcCtD
Nafarelin—Weight decreased—Irinotecan—colon cancer	0.00595	0.00595	CcSEcCtD
Nafarelin—Acute coronary syndrome—Vincristine—colon cancer	0.00594	0.00594	CcSEcCtD
Nafarelin—Myocardial infarction—Vincristine—colon cancer	0.0059	0.0059	CcSEcCtD
Nafarelin—Hepatic function abnormal—Capecitabine—colon cancer	0.00583	0.00583	CcSEcCtD
Nafarelin—Acute coronary syndrome—Irinotecan—colon cancer	0.00578	0.00578	CcSEcCtD
Nafarelin—Myocardial infarction—Irinotecan—colon cancer	0.00575	0.00575	CcSEcCtD
Nafarelin—Oliguria—Methotrexate—colon cancer	0.00567	0.00567	CcSEcCtD
Nafarelin—Herpes simplex—Methotrexate—colon cancer	0.00567	0.00567	CcSEcCtD
Nafarelin—Eye pain—Capecitabine—colon cancer	0.00564	0.00564	CcSEcCtD
Nafarelin—Acute coronary syndrome—Fluorouracil—colon cancer	0.00554	0.00554	CcSEcCtD
Nafarelin—Myocardial infarction—Fluorouracil—colon cancer	0.00551	0.00551	CcSEcCtD
Nafarelin—Libido decreased—Capecitabine—colon cancer	0.00549	0.00549	CcSEcCtD
Nafarelin—Conjunctivitis—Fluorouracil—colon cancer	0.00546	0.00546	CcSEcCtD
Nafarelin—Hot flush—Capecitabine—colon cancer	0.00544	0.00544	CcSEcCtD
Nafarelin—Increased appetite—Capecitabine—colon cancer	0.00542	0.00542	CcSEcCtD
Nafarelin—Menopausal symptoms—Capecitabine—colon cancer	0.0054	0.0054	CcSEcCtD
Nafarelin—Epistaxis—Fluorouracil—colon cancer	0.0053	0.0053	CcSEcCtD
Nafarelin—Rhinitis—Irinotecan—colon cancer	0.00528	0.00528	CcSEcCtD
Nafarelin—Sinusitis—Fluorouracil—colon cancer	0.00527	0.00527	CcSEcCtD
Nafarelin—Pulmonary embolism—Methotrexate—colon cancer	0.00522	0.00522	CcSEcCtD
Nafarelin—Cerebrovascular accident—Capecitabine—colon cancer	0.0052	0.0052	CcSEcCtD
Nafarelin—Cystitis noninfective—Methotrexate—colon cancer	0.0051	0.0051	CcSEcCtD
Nafarelin—Rhinitis—Fluorouracil—colon cancer	0.00505	0.00505	CcSEcCtD
Nafarelin—Disturbance in sexual arousal—Capecitabine—colon cancer	0.00505	0.00505	CcSEcCtD
Nafarelin—Cystitis—Methotrexate—colon cancer	0.00504	0.00504	CcSEcCtD
Nafarelin—Mood swings—Capecitabine—colon cancer	0.00482	0.00482	CcSEcCtD
Nafarelin—Alopecia—Vincristine—colon cancer	0.00478	0.00478	CcSEcCtD
Nafarelin—Mental disorder—Vincristine—colon cancer	0.00474	0.00474	CcSEcCtD
Nafarelin—Bladder pain—Methotrexate—colon cancer	0.00472	0.00472	CcSEcCtD
Nafarelin—Neoplasm—Methotrexate—colon cancer	0.00472	0.00472	CcSEcCtD
Nafarelin—Gynaecomastia—Methotrexate—colon cancer	0.00467	0.00467	CcSEcCtD
Nafarelin—Dry skin—Capecitabine—colon cancer	0.00467	0.00467	CcSEcCtD
Nafarelin—Alopecia—Irinotecan—colon cancer	0.00465	0.00465	CcSEcCtD
Nafarelin—Gastritis—Capecitabine—colon cancer	0.00451	0.00451	CcSEcCtD
Nafarelin—Muscular weakness—Capecitabine—colon cancer	0.00449	0.00449	CcSEcCtD
Nafarelin—Alopecia—Fluorouracil—colon cancer	0.00446	0.00446	CcSEcCtD
Nafarelin—Abdominal distension—Capecitabine—colon cancer	0.00443	0.00443	CcSEcCtD
Nafarelin—Sweating increased—Capecitabine—colon cancer	0.00429	0.00429	CcSEcCtD
Nafarelin—Vertigo—Vincristine—colon cancer	0.00423	0.00423	CcSEcCtD
Nafarelin—Vertigo—Irinotecan—colon cancer	0.00412	0.00412	CcSEcCtD
Nafarelin—Dysuria—Capecitabine—colon cancer	0.00412	0.00412	CcSEcCtD
Nafarelin—Convulsion—Vincristine—colon cancer	0.00408	0.00408	CcSEcCtD
Nafarelin—Myalgia—Vincristine—colon cancer	0.00401	0.00401	CcSEcCtD
Nafarelin—Weight increased—Capecitabine—colon cancer	0.00401	0.00401	CcSEcCtD
Nafarelin—Weight decreased—Capecitabine—colon cancer	0.00398	0.00398	CcSEcCtD
Nafarelin—Depression—Capecitabine—colon cancer	0.00391	0.00391	CcSEcCtD
Nafarelin—Acute coronary syndrome—Capecitabine—colon cancer	0.00387	0.00387	CcSEcCtD
Nafarelin—Cerebrovascular accident—Methotrexate—colon cancer	0.00387	0.00387	CcSEcCtD
Nafarelin—Myocardial infarction—Capecitabine—colon cancer	0.00385	0.00385	CcSEcCtD
Nafarelin—Oedema—Vincristine—colon cancer	0.00384	0.00384	CcSEcCtD
Nafarelin—Conjunctivitis—Capecitabine—colon cancer	0.00382	0.00382	CcSEcCtD
Nafarelin—Convulsion—Fluorouracil—colon cancer	0.0038	0.0038	CcSEcCtD
Nafarelin—Oedema—Irinotecan—colon cancer	0.00374	0.00374	CcSEcCtD
Nafarelin—Chest pain—Fluorouracil—colon cancer	0.00374	0.00374	CcSEcCtD
Nafarelin—Myalgia—Fluorouracil—colon cancer	0.00374	0.00374	CcSEcCtD
Nafarelin—Hyperhidrosis—Vincristine—colon cancer	0.00371	0.00371	CcSEcCtD
Nafarelin—Epistaxis—Capecitabine—colon cancer	0.0037	0.0037	CcSEcCtD
Nafarelin—Shock—Irinotecan—colon cancer	0.00368	0.00368	CcSEcCtD
Nafarelin—Anorexia—Vincristine—colon cancer	0.00366	0.00366	CcSEcCtD
Nafarelin—Hyperhidrosis—Irinotecan—colon cancer	0.00362	0.00362	CcSEcCtD
Nafarelin—Mood swings—Methotrexate—colon cancer	0.00359	0.00359	CcSEcCtD
Nafarelin—Oedema—Fluorouracil—colon cancer	0.00358	0.00358	CcSEcCtD
Nafarelin—Anorexia—Irinotecan—colon cancer	0.00357	0.00357	CcSEcCtD
Nafarelin—Rhinitis—Capecitabine—colon cancer	0.00353	0.00353	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Vincristine—colon cancer	0.0035	0.0035	CcSEcCtD
Nafarelin—Insomnia—Vincristine—colon cancer	0.00347	0.00347	CcSEcCtD
Nafarelin—Paraesthesia—Vincristine—colon cancer	0.00345	0.00345	CcSEcCtD
Nafarelin—Anorexia—Fluorouracil—colon cancer	0.00341	0.00341	CcSEcCtD
Nafarelin—Insomnia—Irinotecan—colon cancer	0.00338	0.00338	CcSEcCtD
Nafarelin—Paraesthesia—Irinotecan—colon cancer	0.00336	0.00336	CcSEcCtD
Nafarelin—Decreased appetite—Vincristine—colon cancer	0.00334	0.00334	CcSEcCtD
Nafarelin—Dyspnoea—Irinotecan—colon cancer	0.00333	0.00333	CcSEcCtD
Nafarelin—Constipation—Vincristine—colon cancer	0.00328	0.00328	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00326	0.00326	CcSEcCtD
Nafarelin—Decreased appetite—Irinotecan—colon cancer	0.00325	0.00325	CcSEcCtD
Nafarelin—Insomnia—Fluorouracil—colon cancer	0.00324	0.00324	CcSEcCtD
Nafarelin—Paraesthesia—Fluorouracil—colon cancer	0.00322	0.00322	CcSEcCtD
Nafarelin—Constipation—Irinotecan—colon cancer	0.0032	0.0032	CcSEcCtD
Nafarelin—Dyspnoea—Fluorouracil—colon cancer	0.00319	0.00319	CcSEcCtD
Nafarelin—Decreased appetite—Fluorouracil—colon cancer	0.00311	0.00311	CcSEcCtD
Nafarelin—Alopecia—Capecitabine—colon cancer	0.00311	0.00311	CcSEcCtD
Nafarelin—Mental disorder—Capecitabine—colon cancer	0.00309	0.00309	CcSEcCtD
Nafarelin—Malnutrition—Capecitabine—colon cancer	0.00307	0.00307	CcSEcCtD
Nafarelin—Dysuria—Methotrexate—colon cancer	0.00306	0.00306	CcSEcCtD
Nafarelin—Dysgeusia—Capecitabine—colon cancer	0.003	0.003	CcSEcCtD
Nafarelin—Depression—Methotrexate—colon cancer	0.00291	0.00291	CcSEcCtD
Nafarelin—Urticaria—Fluorouracil—colon cancer	0.00285	0.00285	CcSEcCtD
Nafarelin—Conjunctivitis—Methotrexate—colon cancer	0.00284	0.00284	CcSEcCtD
Nafarelin—Epistaxis—Methotrexate—colon cancer	0.00276	0.00276	CcSEcCtD
Nafarelin—Vertigo—Capecitabine—colon cancer	0.00276	0.00276	CcSEcCtD
Nafarelin—Asthenia—Vincristine—colon cancer	0.00276	0.00276	CcSEcCtD
Nafarelin—Palpitations—Capecitabine—colon cancer	0.00271	0.00271	CcSEcCtD
Nafarelin—Asthenia—Irinotecan—colon cancer	0.00268	0.00268	CcSEcCtD
Nafarelin—Diarrhoea—Vincristine—colon cancer	0.00263	0.00263	CcSEcCtD
Nafarelin—Arthralgia—Capecitabine—colon cancer	0.00261	0.00261	CcSEcCtD
Nafarelin—Chest pain—Capecitabine—colon cancer	0.00261	0.00261	CcSEcCtD
Nafarelin—Myalgia—Capecitabine—colon cancer	0.00261	0.00261	CcSEcCtD
Nafarelin—Diarrhoea—Irinotecan—colon cancer	0.00256	0.00256	CcSEcCtD
Nafarelin—Dizziness—Vincristine—colon cancer	0.00254	0.00254	CcSEcCtD
Nafarelin—Pruritus—Fluorouracil—colon cancer	0.00253	0.00253	CcSEcCtD
Nafarelin—Oedema—Capecitabine—colon cancer	0.0025	0.0025	CcSEcCtD
Nafarelin—Dizziness—Irinotecan—colon cancer	0.00247	0.00247	CcSEcCtD
Nafarelin—Shock—Capecitabine—colon cancer	0.00246	0.00246	CcSEcCtD
Nafarelin—Diarrhoea—Fluorouracil—colon cancer	0.00245	0.00245	CcSEcCtD
Nafarelin—Vomiting—Vincristine—colon cancer	0.00244	0.00244	CcSEcCtD
Nafarelin—Rash—Vincristine—colon cancer	0.00242	0.00242	CcSEcCtD
Nafarelin—Hyperhidrosis—Capecitabine—colon cancer	0.00242	0.00242	CcSEcCtD
Nafarelin—Dermatitis—Vincristine—colon cancer	0.00242	0.00242	CcSEcCtD
Nafarelin—Headache—Vincristine—colon cancer	0.00241	0.00241	CcSEcCtD
Nafarelin—Anorexia—Capecitabine—colon cancer	0.00239	0.00239	CcSEcCtD
Nafarelin—Vomiting—Irinotecan—colon cancer	0.00238	0.00238	CcSEcCtD
Nafarelin—Dizziness—Fluorouracil—colon cancer	0.00237	0.00237	CcSEcCtD
Nafarelin—Rash—Irinotecan—colon cancer	0.00236	0.00236	CcSEcCtD
Nafarelin—Dermatitis—Irinotecan—colon cancer	0.00236	0.00236	CcSEcCtD
Nafarelin—Headache—Irinotecan—colon cancer	0.00234	0.00234	CcSEcCtD
Nafarelin—Alopecia—Methotrexate—colon cancer	0.00232	0.00232	CcSEcCtD
Nafarelin—Mental disorder—Methotrexate—colon cancer	0.0023	0.0023	CcSEcCtD
Nafarelin—Malnutrition—Methotrexate—colon cancer	0.00228	0.00228	CcSEcCtD
Nafarelin—Nausea—Vincristine—colon cancer	0.00228	0.00228	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00228	0.00228	CcSEcCtD
Nafarelin—Vomiting—Fluorouracil—colon cancer	0.00228	0.00228	CcSEcCtD
Nafarelin—Insomnia—Capecitabine—colon cancer	0.00226	0.00226	CcSEcCtD
Nafarelin—Rash—Fluorouracil—colon cancer	0.00226	0.00226	CcSEcCtD
Nafarelin—Dermatitis—Fluorouracil—colon cancer	0.00226	0.00226	CcSEcCtD
Nafarelin—Paraesthesia—Capecitabine—colon cancer	0.00225	0.00225	CcSEcCtD
Nafarelin—Headache—Fluorouracil—colon cancer	0.00224	0.00224	CcSEcCtD
Nafarelin—Dysgeusia—Methotrexate—colon cancer	0.00224	0.00224	CcSEcCtD
Nafarelin—Dyspnoea—Capecitabine—colon cancer	0.00223	0.00223	CcSEcCtD
Nafarelin—Nausea—Irinotecan—colon cancer	0.00222	0.00222	CcSEcCtD
Nafarelin—Decreased appetite—Capecitabine—colon cancer	0.00218	0.00218	CcSEcCtD
Nafarelin—Constipation—Capecitabine—colon cancer	0.00214	0.00214	CcSEcCtD
Nafarelin—Nausea—Fluorouracil—colon cancer	0.00213	0.00213	CcSEcCtD
Nafarelin—Vertigo—Methotrexate—colon cancer	0.00205	0.00205	CcSEcCtD
Nafarelin—Urticaria—Capecitabine—colon cancer	0.00199	0.00199	CcSEcCtD
Nafarelin—Convulsion—Methotrexate—colon cancer	0.00198	0.00198	CcSEcCtD
Nafarelin—Myalgia—Methotrexate—colon cancer	0.00194	0.00194	CcSEcCtD
Nafarelin—Chest pain—Methotrexate—colon cancer	0.00194	0.00194	CcSEcCtD
Nafarelin—Arthralgia—Methotrexate—colon cancer	0.00194	0.00194	CcSEcCtD
Nafarelin—Hyperhidrosis—Methotrexate—colon cancer	0.0018	0.0018	CcSEcCtD
Nafarelin—Asthenia—Capecitabine—colon cancer	0.0018	0.0018	CcSEcCtD
Nafarelin—Anorexia—Methotrexate—colon cancer	0.00178	0.00178	CcSEcCtD
Nafarelin—Pruritus—Capecitabine—colon cancer	0.00177	0.00177	CcSEcCtD
Nafarelin—Diarrhoea—Capecitabine—colon cancer	0.00171	0.00171	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Methotrexate—colon cancer	0.0017	0.0017	CcSEcCtD
Nafarelin—Insomnia—Methotrexate—colon cancer	0.00169	0.00169	CcSEcCtD
Nafarelin—Paraesthesia—Methotrexate—colon cancer	0.00167	0.00167	CcSEcCtD
Nafarelin—Dyspnoea—Methotrexate—colon cancer	0.00166	0.00166	CcSEcCtD
Nafarelin—Dizziness—Capecitabine—colon cancer	0.00166	0.00166	CcSEcCtD
Nafarelin—Decreased appetite—Methotrexate—colon cancer	0.00162	0.00162	CcSEcCtD
Nafarelin—Vomiting—Capecitabine—colon cancer	0.00159	0.00159	CcSEcCtD
Nafarelin—Rash—Capecitabine—colon cancer	0.00158	0.00158	CcSEcCtD
Nafarelin—Dermatitis—Capecitabine—colon cancer	0.00158	0.00158	CcSEcCtD
Nafarelin—Headache—Capecitabine—colon cancer	0.00157	0.00157	CcSEcCtD
Nafarelin—Nausea—Capecitabine—colon cancer	0.00149	0.00149	CcSEcCtD
Nafarelin—Urticaria—Methotrexate—colon cancer	0.00148	0.00148	CcSEcCtD
Nafarelin—Asthenia—Methotrexate—colon cancer	0.00134	0.00134	CcSEcCtD
Nafarelin—Pruritus—Methotrexate—colon cancer	0.00132	0.00132	CcSEcCtD
Nafarelin—Diarrhoea—Methotrexate—colon cancer	0.00127	0.00127	CcSEcCtD
Nafarelin—Dizziness—Methotrexate—colon cancer	0.00123	0.00123	CcSEcCtD
Nafarelin—Vomiting—Methotrexate—colon cancer	0.00118	0.00118	CcSEcCtD
Nafarelin—Rash—Methotrexate—colon cancer	0.00117	0.00117	CcSEcCtD
Nafarelin—Dermatitis—Methotrexate—colon cancer	0.00117	0.00117	CcSEcCtD
Nafarelin—Headache—Methotrexate—colon cancer	0.00117	0.00117	CcSEcCtD
Nafarelin—Nausea—Methotrexate—colon cancer	0.00111	0.00111	CcSEcCtD
